Sponsor:MediciNovaBrief Summary: A Phase 2b/3 multicenter, randomized, double-blind, placebo-controlled, parallel group study to evaluate the efficacy, safety and tolerability of…
Sponsor:Leigh R. Hochberg, MD, PhD.Brief Summary: The purpose of this study is to obtain preliminary device safety information and demonstrate…
Sponsor:Loma Linda UniversityBrief Summary: This study is being conducted to help the investigators better understand how the new FDA approved…
Sponsor:University of Kansas Medical CenterBrief Summary: The purpose of this study is to determine if memantine at 20 mg BID…
Sponsor:ProgenaBiomeBrief Summary: This study seeks to correlate microbiome sequencing data with information provided by patients and their medical records regarding…
Sponsor:University of MiamiBrief Summary: The goals of this study are: (1) to better understand the relationship between the phenotype and…
Sponsor:Alexion PharmaceuticalsBrief Summary: The purpose of the study is to assess the efficacy and safety of ravulizumab for the treatment…
Sponsor:University of California, San FranciscoBrief Summary: Frontotemporal Lobar Degeneration (FTLD) is the neuropathological term for a collection of rare neurodegenerative…
Sponsor:Mitsubishi Tanabe Pharma America Inc.Brief Summary: REFINE-ALS is a prospective, observational, longitudinal, multicenter study designed to identify biomarkers to serve…
Sponsor:BiogenBrief Summary: The primary objective of Parts A and B of this study is to evaluate the safety, tolerability, and…
